State Ledger
Company profile

PUMA BIOTECHNOLOGY, INC. CIK 1401667

Ticker
PBYI (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Los Angeles, CA
Fiscal year end
2025 (FY)
Market Data
Close
$10.29
Change
+$0.30
Change %
3.00%
Volume
15,942

PBYI · trading date Oct 9, 2026 · previous close $9.99 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$228.37M
Net income
$31.11M
Total assets
$216.30M
Total liabilities
$85.96M
Stockholders' equity
$130.34M
Cash & equivalents
$29.64M
Operating income
$37.30M
Operating cash flow
$41.80M
Capital expenditures
$71.0K

Fiscal year 2025, via 10-K filed 2026-02-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
16.3%
Net margin
13.6%
Free cash flow
$41.73M
Free cash flow margin
18.3%
Liabilities / assets
39.7%
Equity / assets
60.3%
CapEx / revenue
0.0%
Operating cash flow / net income
1.34×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $228.37M $31.11M $216.30M $85.96M $130.34M
2024 $230.47M $30.28M $213.33M $121.21M $92.13M
2023 $235.64M $21.59M $230.53M $177.09M $53.44M
2022 $228.03M $2.0K $222.06M $200.45M $21.61M
2021 $253.16M -$29.13M $226.59M $229.03M -$2.45M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-16
Financials filed via
Form 10-K
filed 2026-02-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Los Angeles, CA
10880 WILSHIRE BLVD.
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:16 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies